The North America Precision Diagnostics Market would witness market growth of 17.5% CAGR during the forecast period (2024-2031).
The US market dominated the North America Precision Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $16,362.9 million by 2031. The Canada market is experiencing a CAGR of 19.7% during (2024 - 2031). Additionally, The Mexico market is exhibiting a CAGR of 20.3% during (2024 - 2031).
Precision diagnostics refers to a sophisticated approach in healthcare that involves using advanced technologies and methodologies to diagnose diseases accurately at a molecular or genetic level. This approach identifies specific biomarkers, genetic mutations, or other molecular signatures unique to a patient's condition.
Moreover, Precision diagnostics aims to tailor medical treatments and interventions based on these individual characteristics, thereby optimizing therapeutic outcomes and minimizing potential side effects.
With higher incidences of cancer, there is a growing demand for advanced diagnostic technologies. This includes genetic testing, next-generation sequencing (NGS), and molecular diagnostics to accurately diagnose and subtype different types of cancer prevalent in the Mexican population. According to All.Can, cancer rank as the third leading cause of death in Mexico, with over 195,000 new cases reported in 2020. The most prevalent types included breast (29,929 cases), prostate (26,742 cases), thyroid (11,227 cases), colon (11,191 cases), and cervical cancer (9,439 cases).
Free Valuable Insights: The Precision Diagnostics Market is Predict to reach USD 55.03 Billion by 2031, at a CAGR of 18.0%
Based on End-use, the market is segmented into Clinical Laboratories, Hospitals, and Others. Based on Type, the market is segmented into Genetic Tests, Esoteric Tests, Direct to Consumer Tests, and Others. Based on Application, the market is segmented into Oncology, Respiratory Diseases, CNS Disorders, Immunology, Skin Diseases, Genetic Diseases, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
By End-use
By Type
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 